HIV PRE-EXPOSURE PROPHYLAXIS
Clinical trials for HIV PRE-EXPOSURE PROPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new HIV PRE-EXPOSURE PROPHYLAXIS trials appear
Sign up with your email to follow new studies for HIV PRE-EXPOSURE PROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New approach aims to boost HIV prevention in latine communities
Prevention Recruiting nowThis study is testing whether offering a long-acting injectable HIV prevention medication (lenacapavir) through a trusted community organization helps Latine gay/bisexual men and transgender women stay on the medication longer. The program provides culturally-tailored support thr…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE4 • Sponsor: Duke University • Aim: Prevention
Last updated Mar 30, 2026 14:32 UTC
-
Monthly pill could revolutionize HIV prevention for women
Prevention Recruiting nowThis study is testing whether a new monthly oral pill (MK-8527) works better than the current standard daily pill to prevent HIV infection in women. It will involve about 4,580 HIV-negative women who are sexually active. The research will compare how well each option prevents HIV…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Mar 30, 2026 14:31 UTC
-
One shot a year to stop HIV? major trial tests new prevention method
Prevention Recruiting nowThis study is testing a new yearly injection called lenacapavir to prevent HIV infection in people at risk. It will enroll 350 participants to see if the shot is safe and how the drug behaves in the body over a year. The goal is to offer a convenient, long-acting alternative to d…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Prevention
Last updated Mar 30, 2026 14:30 UTC
-
Monthly HIV prevention pill could replace daily medication
Prevention Recruiting nowThis study is testing whether a new monthly oral pill called MK-8527 works as well as or better than standard daily PrEP medication to prevent HIV infection. The trial will involve 4,390 HIV-negative adults at risk of HIV exposure. Researchers will compare how effective the month…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Mar 20, 2026 14:48 UTC